Class I and class II major histocompatibility complex antigen expression on hepatocytes: A study in children with liver disease

No abstract is available for this paper.

• Publication year

  1990

• Venue

  Hepatology

• Publication date

  1990-08-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1002/hep.1840120208PMID 2118117
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hepatitis B Virus and HLA Antigen Display in the Liver During Chronic Hepatitis B Virus Infection

  2007cited by this paper
• Interleukin-1 and interleukin-2 activity in chronic hepatitis B virus infection.

  1988cited by this paper
• Expression of class I and class II major histocompatibility complex antigens on human hepatocytes

  1988cited by this paper
• Early induction of MHC antigens in human liver grafts. An immunohistologic study.

  1988cited by this paper
• Synergistic interaction of cyclosporine A with interleukin 2 receptor monoclonal antibody therapy.

  1988cited by this paper
• Beta-2-microglobulin expression in the liver after liver transplantation.

  1988cited by this paper
• ANALYSIS OF SEQUENTIAL CHANGES IN MAJOR HISTOCOMPATIBILITY COMPLEX EXPRESSION IN HUMAN LIVER GRAFTS AFTER TRANSPLANTATION

  1988cited by this paper
• Increased HLA-DR antigen expression in human hepatocytes after liver transplantation: kinetic analysis using fine needle aspiration biopsy.

  1988cited by this paper
• HLA class I antigen display on hepatocyte membrane in chronic hepatitis B virus infection: Its role in the pathogenesis of chronic type B hepatitis

  1987cited by this paper
• Primary sclerosing cholangitis in childhood.

  1987cited by this paper
• HLA-A,B,C, HLA-D/DR and HLA-D/DQ expression on unfixed liver biopsy sections from patients with chronic liver disease.

  1987cited by this paper
• INCREASED EXPRESSION OF CLASS I MAJOR HISTOCOMPATIBILITY COMPLEX ANTIGENS ON HEPATOCYTES IN REJECTING HUMAN LIVER ALLOGRAFTS

  1987cited by this paper
• In situ distribution of major histocompatibility complex products and viral antigens in chronic hepatitis B virus infection: Evidence that HBc‐containing hepatocytes may express HLA‐DR antigens

  1986cited by this paper
• Relationship of HLA protein display to activation of 2-5A synthetase in HBe antigen or anti-HBe positive chronic HBV infection.

  1986cited by this paper
• Hepatic beta 2-microglobulin distribution in primary biliary cirrhosis.

  1986cited by this paper
• HLA class I antigens on the hepatocyte membrane during recovery from acute hepatitis B virus infection and during interferon therapy in chronic hepatitis B virus infection

  1986influential reference
• Expression of HLA class I antigens on hepatocytes in liver disease.

  1986influential reference
• Expression of beta 2-microglobulin on hepatocytes in acute and chronic type B hepatitis.

  1986cited by this paper
• The regulation of expression of major histocompatibility complex products.

  1986cited by this paper
• Evidence for a deficiency of interferon production in patients with chronic hepatitis B virus infection acquired in adult life

  1986cited by this paper
• Hepatic β2-microglobulin distribution in primary biliary cirrhosis

  1986cited by this paper
• Expression of β2−microglobulin on hepatocytes in acute and chronic type B hepatitis

  1986cited by this paper
• Expression of beta-2-microglobulin on hepatocytes after liver transplantation.

  1985cited by this paper
• Human dermal fibroblasts present tetanus toxoid antigen to antigen-specific T cell clones.

  1985cited by this paper
• Interferon-gamma induces HLA-DR expression by thyroid epithelium.

  1985cited by this paper
• Ultrastructural immunocytochemical demonstration of HLA class I antigens in human pathological liver tissue

  1985cited by this paper
• THE DETAILED DISTRIBUTION OF HLA‐A, B, C ANTIGENS IN NORMAL HUMAN ORGANS

  1984cited by this paper
• Distribution of the major histocompatibility complex antigens on different cellular components of human liver.

  1984cited by this paper
• Epithelial cells expressing aberrant MHC class II determinants can present antigen to cloned human T cells

  1984cited by this paper
• Lymphocyte subpopulations at the site of "piecemeal" necrosis in end stage chronic liver diseases and rejecting liver allografts in cyclosporine-treated patients.

  1984cited by this paper
• Pure interferon gamma enhances class II HLA antigens on human monocyte cell lines

  1984cited by this paper
• Immune interferon activates multiple class II major histocompatibility complex genes and the associated invariant chain gene in human endothelial cells and dermal fibroblasts.

  1984cited by this paper
• THE DETAILED DISTRIBUTION OF MHC CLASS II ANTIGENS IN NORMAL HUMAN ORGANS

  1984cited by this paper
• Aberrant expression of HLA-DR antigen on thyrocytes in Graves' disease: relevance for autoimmunity.

  1983cited by this paper
• Monomorphic anti-HLA-A,B,C monoclonal antibodies detecting molecular subunits and combinatorial determinants.

  1982cited by this paper
• EXPRESSION OF Ia‐LIKE ANTIGENS IN NORMAL HUMAN NONLYMPHOID TISSUES

  1981cited by this paper
• Immunohistochemical analysis of HLA (A, B, C) antigens in liver disease using a monoclonal antibody.

  1981cited by this paper
• Role of MHC gene products in immune regulation.

  1981cited by this paper
• Distribution of HLA class 1 antigens in normal human tissue and in mammary cancer.

  1981cited by this paper
• Two populations of Ia-like molecules on a human B cell line.

  1980cited by this paper
• Beta2-microglobulin distribution in human normal tissues.

  1976cited by this paper
• β2‐Microglobulin distribution in human normal tissues

  1976cited by this paper
• Diseases of the liver and biliary tract : standardization of nomenclature, diagnostic criteria, and diagnostic methodology

  1976cited by this paper
• BIRTH CONTROL FOR PROBLEM PARENTS.

  1964cited by this paper

• Inflammation and immunity in liver homeostasis and disease: a nexus of hepatocytes, nonparenchymal cells and immune cells

  2025cites this paper
• Role of regulatory T cells in inflammatory liver diseases.

  2025cites this paper
• The significance of gut microbiota in the etiology of autoimmune hepatitis: a narrative review

  2024cites this paper
• B and T cells: (Still) the dominant orchestrators in autoimmune hepatitis.

  2024cites this paper
• HERV1-env Induces Unfolded Protein Response Activation in Autoimmune Liver Disease: A Potential Mechanism for Regulatory T Cell Dysfunction.

  2023cites this paper
• Global koff‐rates of polyclonal T‐cell populations merge subclonal avidities and predict functionality

  2022cites this paper
• Dysfunctional Immune Regulation in Autoimmune Hepatitis: From Pathogenesis to Novel Therapies

  2021cites this paper
• T cell–mediated autoimmunity in immune thrombocytopenia

  2021cites this paper
• Regulatory T cells in autoimmune hepatitis: Un updated overview.

  2021cites this paper
• Hepatitis

  2020cites this paper
• Autoimmunhepatitis (AIH)

  2020cites this paper
• Autoimmune Hepatitis

  2020cites this paper
• Autoimmune Liver Disease

  2020cites this paper
• The MHC II-CD4 Immunologic Synapse in Alcoholic Hepatitis and Autoimmune Liver Pathology: The Role of Aberrant MHC II in Hepatocytes.

  2019cites this paper
• Are B cells altered in the decidua of women with preterm or term labor?

  2019cites this paper
• Novel Diagnostic and Therapeutic Strategies in Juvenile Autoimmune Hepatitis

  2019cites this paper
• Autoimmune hepatitis

  2018cites this paper
• Current and future perspectives in autoimmune hepatitis.

  2018cites this paper
• Fumarate hydratase-specific T cell response in Chinese patients with autoimmune hepatitis.

  2018cites this paper
• Hepatocyte‐induced CD4+ T cell alloresponse is associated with major histocompatibility complex class II up‐regulation on hepatocytes and suppressible by regulatory T cells

  2018cites this paper
• Chapter 6.2. Immune Function–related Liver Disease and ESPGHAN's Contribution to the Advancement of Science in the Last 3 Decades

  2018cites this paper
• Characteristic patterns of HLA presentation and T cell differentiation in adult-onset Still’s disease

  2018cites this paper
• Mechanisms of CD8+ T cell‐mediated suppression of HIV/SIV replication

  2018cites this paper
• How Cancers Escape Immune Destruction and Mechanisms of Action for the New Significantly Active Immune Therapies: Helping Nonimmunologists Decipher Recent Advances.

  2016cites this paper
• Autoimmune Hepatitis: Factors Involved in Initiation and Methods of Diagnosis and Treatment.

  2016cites this paper
• α1-antitrypsin Deficiency: A Misfolded Secretory Protein Variant with Unique Effects on the Endoplasmic Reticulum

  2016cites this paper
• Contemporary issues and future directions in autoimmune hepatitis

  2016cites this paper
• Cell Mediators of Autoimmune Hepatitis and Their Therapeutic Implications

  2015influential citation
• Paediatric Autoimmune Liver Disease

  2015cites this paper
• Update on Autoimmune Hepatitis

  2015cites this paper
• Autoimmune hepatitis: a classic autoimmune liver disease.

  2014cites this paper
• Cytotoxic Markers Associate With Protection Against Malaria in Human Volunteers Immunized With Plasmodium falciparum Sporozoites

  2014cites this paper
• Adult Human Hepatocytes Promote CD4+ T-Cell Hyporesponsiveness Via Interleukin-10-Producing Allogeneic Dendritic Cells

  2014cites this paper
• Chapter 61 – Hepatitis

  2014cites this paper
• Autoimmune hepatitis.

  2013cites this paper
• CD8+ T‐cell effector function and transcriptional regulation during HIV pathogenesis

  2013cites this paper
• Autoimmune hepatitis: a comprehensive review.

  2013cites this paper
• Mechanisms Underlying the Hepatotoxicity of Nonsteroidal Antiinflammatory Drugs

  2013cites this paper
• Autoimmune Hepatitis: A Review on Disease Pathology and Novel Vitamin D-Associated Disease Progression

  2013cites this paper
• Cutting Edge Issues in Autoimmune Hepatitis

  2012cites this paper
• Chapter 8 – Immune Pathogenesis of Viral Hepatitis B and C

  2012cites this paper
• Effectors and regulators of cellular immune response in autoimmune liver disease

  2012cites this paper
• Living in a house of cards: re‐evaluating CD8+ T‐cell immune correlates against HIV

  2011cites this paper
• Pathogenesis of autoimmune hepatitis.

  2011cites this paper
• 1,25‐Dihydroxyvitamin D3 enhances NK susceptibility of human melanoma cells via Hsp60‐mediated FAS expression

  2011cites this paper
• Identification of T cell epitopes on soluble liver antigen in Chinese patients with auto‐immune hepatitis

  2011cites this paper
• Serine protease inhibitors and cytotoxic T lymphocytes

  2010cites this paper
• Distinct roles of cytolytic effector molecules for antigen‐restricted killing by CTL in vivo

  2010cites this paper
• Immune privilege and alopecia areata

  2010cites this paper
• Adaptive Immunity in Autoimmune Hepatitis

  2010cites this paper
• Hepatitis B and the Immune System

  2010cites this paper
• Hemophagocytic lymphohistiocytosis in Texas: Observations on ethnicity and race

  2010cites this paper
• Aetiopathogenesis of autoimmune hepatitis.

  2010cites this paper
• Bile duct ligation in neonatal rats: Is it a valid experimental model for biliary atresia studies?

  2009cites this paper
• Autoimmune hepatitis

  2009cites this paper
• IMMUNE RESPONSES IN AUTOIMMUNE HEPATITIS: EFFECT OF PREDNISONE AND AZATHIOPRINE TREATMENT: CASE REPORT

  2009cites this paper
• Imaging effector functions of human cytotoxic CD4+ T cells specific for Plasmodium falciparum circumsporozoite protein.

  2009cites this paper
• Getting a GRASP on CASP: properties and role of the cytohesin‐associated scaffolding protein in immunity

  2009cites this paper
• Cellular effector mechanisms against Plasmodium liver stages

  2008cites this paper
• Immune privilege and the skin.

  2008cites this paper
• Detection of perforin and granzyme B mRNA expressing cells in lichen sclerosus

  2007cites this paper
• Autoimmune hepatitis in children: diagnosis, pathology and treatment

  2007cites this paper
• The molecular makeup and function of regulatory and effector synapses

  2007cites this paper
• Activation‐induced upregulation of inhibitory killer Ig‐like receptors is regulated by protein kinase C

  2007cites this paper
• HLA class II influences humoral autoimmunity in patients with type 2 autoimmune hepatitis.

  2006cites this paper
• Cytotoxic CD4+ T cells in viral hepatitis

  2006cites this paper
• Autoreactive T cells: any evidence in autoimmune liver disease?

  2005cites this paper
• Expression rate of cytokine mRNA in the liver of chronic hepatitis C: Comparison with chronic hepatitis B

  2005cites this paper
• Immune-mediated liver injury: prognostic value of CD4+, CD8+, and CD68+ in infants with extrahepatic biliary atresia.

  2005cites this paper
• Quantification of T‐cell–mediated apoptosis in heterogeneous leukemia populations using four‐color multiparameter flow cytometry

  2005cites this paper
• Effect of tetravalent bispecific CD19×CD3 recombinant antibody construct and CD28 costimulation on lysis of malignant B cells from patients with chronic lymphocytic leukemia by autologous T cells

  2004cites this paper
• Mechanisms of autoimmune hepatitis

  2004cites this paper
• Induction of colitis in cftr-/- mice results in bile duct injury.

  2004cites this paper
• Autoimmune Hepatitis and Sclerosing Cholangitis

  2004cites this paper
• Autoimmune hepatitis and sclerosing cholangitis.

  2004cites this paper
• Collapse and restoration of MHC class-I-dependent immune privilege: exploiting the human hair follicle as a model.

  2004cites this paper
• Immunopathogenetic and therapeutic aspects of autoimmune hepatitis

  2003cites this paper
• Autoimmune hepatitis: evolving concepts.

  2003cites this paper
• Autoimmune hepatitis.

  2003cites this paper
• Steatohepatitis in obese individuals.

  2002cites this paper
• Pathogenesis of autoimmune hepatitis.

  2002cites this paper
• Treatment of nonalcoholic fatty liver disease.

  2002cites this paper
• Clinical and Experimental Studies of Organ-Specific Autoimmune Diseases

  2001cites this paper
• Autoimmune overlap syndromes

  2001cites this paper
• Clinical and Experimental Studies of Organ-Specific Autoimmune Diseases With Special Reference to Addison's Disease and Autoimmune Hepatitis

  2001cites this paper
• Autoantibodies in liver disease.

  2001cites this paper
• Stoffwechselerkrankungen der Leber

  2000cites this paper
• A study of graft versus host disease using bile duct implants under the kidney capsule.

  2000cites this paper
• Priming of hepatitis C virus–specific cytotoxic t lymphocytes in mice following portal vein injection of a liver‐specific plasmid DNA

  2000cites this paper
• Liver injury in alpha 1-antitrypsin deficiency.

  2000cites this paper
• LIVER INJURY IN ALPHA1-ANTITRYPSIN DEFICIENCY

  2000cites this paper
• The role of T cells in autoimmune hepatitis

  2000cites this paper
• Autoimmune hepatitis: The investigational and clinical challenges

  2000cites this paper
• Chronic liver disease: current concepts of disease mechanisms

  1999cites this paper
• Pathogenesis of autoimmune hepatitis.

  1999cites this paper
• Alpha1-antitrypsin deficiency: from genotype to childhood disease.

  1998cites this paper
• Cordyceps sinensis increases the expression of major histocompatibility complex class II antigens on human hepatoma cell line HA22T/VGH cells.

  1998cites this paper
• Immunological Liver Diseases in Children

  1998cites this paper
• Alpha-1-Antitrypsin Deficiency

  1998cites this paper
• α1‐Antitrypsin Deficiency: From Genotype to Childhood Disease

  1998cites this paper